Low Risk? High Potential? BOTH?!
Top Rebound Candidates: CGON Leads, Followed by AMZN, CADL, and FBRX
Markets often reward patience near well-defined support more than chasing strength. A recent scan surfaced four names sitting close to technical support with solid scores and RSI readings. Below is a practical ranking plus illustrative entry zones, exit targets, percentage returns, and probability estimates. These are investigation candidates only—not trade recommendations. Always confirm live quotes, volume, and the chart on TradingView before acting.
Summary Ranking & Comparison
| Ticker | Score | RSI | Support | Approx. Price | % Above Support | Style | TradingView |
|---|---|---|---|---|---|---|---|
| CGON | 87 | 38 | $66.01 | $67.38 | 2.1% | Rebound with room to run | Chart |
| AMZN | 81 | 48 | $244.30 | $251.52 | 3.0% | Larger-cap recovery | Chart |
| CADL | 77 | 45 | $9.85 | $10.18 | 3.3% | Higher-volatility rebound | Chart |
| FBRX | 78 | — | $76.96 | Near support | Tight | Support-touch watchlist | Chart |
Prices and levels are from the original scan. Verify current quotes on TradingView. Probabilities below are illustrative technical estimates only.
1. CGON — Potential Rebound with Room to Run
Score 87 · RSI 38 · Support $66.01. At \~$67.38 it sits only 2.1% above support. Best balance of score, RSI, and proximity. Look for a reversal candle and rising volume. View CGON on TradingView
| Entry Zone | Exit Target | % Return | Est. Probability* | Notes |
|---|---|---|---|---|
| $66.20 – $67.50 | $72.50 | \~7–9% | 58% | First resistance / conservative |
| $66.20 – $67.50 | $78.00 | \~15–17% | 38% | Extended swing target |
| $66.20 – $67.50 | $82.00+ | \~20%+ | 22% | Requires strong volume & follow-through |
2. AMZN — Larger-Cap Recovery Candidate
Score 81 · RSI 48 · Support $244.30. At \~$251.52 it is \~3% above support. Better liquidity and generally smaller percentage swings. Do not chase; confirm the recent swing high and resistance first. View AMZN on TradingView
| Entry Zone | Exit Target | % Return | Est. Probability* | Notes |
|---|---|---|---|---|
| $245.00 – $252.00 | $265.00 | \~5–7% | 52% | Conservative large-cap bounce |
| $245.00 – $252.00 | $278.00 | \~10–12% | 34% | Toward recent swing area |
| $245.00 – $252.00 | $290.00+ | \~15%+ | 20% | Needs sustained recovery momentum |
3. CADL — Higher-Volatility Rebound Candidate
Score 77 · RSI 45 · Support $9.85. At \~$10.18 it is \~3.3% above support. Can deliver larger percentage moves than large-caps, but verify liquidity, catalyst risk, and clean support tests. View CADL on TradingView
| Entry Zone | Exit Target | % Return | Est. Probability* | Notes |
|---|---|---|---|---|
| $9.90 – $10.30 | $11.20 | \~9–12% | 48% | First nearby resistance |
| $9.90 – $10.30 | $12.50 | \~20–25% | 32% | Higher-volatility swing |
| $9.90 – $10.30 | $14.00+ | \~35%+ | 18% | Requires volume confirmation & no gap risk |
4. FBRX — Support-Touch Watchlist Candidate
Score 78 · Support $76.96. Near-perfect support alignment looks attractive on paper, but price and ticker identity should be verified before further work. A high scanner score alone is not sufficient. View FBRX on TradingView
| Entry Zone | Exit Target | % Return | Est. Probability* | Notes |
|---|---|---|---|---|
| $77.00 – $78.00 | $82.50 | \~6–8% | 45% | Tight support bounce |
| $77.00 – $78.00 | $88.00 | \~13–15% | 28% | Requires clean hold of support |
| $77.00 – $78.00 | $95.00+ | \~20%+ | 15% | Higher risk / verify identity first |
Which Ones to Investigate First
CGON is the first chart to open, followed by AMZN. That ranking reflects the combination of score, RSI, and proximity to support—not a claim of highest expected return. CADL and FBRX stay on the secondary watchlist once the top two are reviewed.
Filters Before Any Entry
- Price holds the identified support (no decisive close below).
- RSI turns upward rather than simply remaining oversold or neutral.
- Volume confirms buying interest on the reversal or bounce.
- Next clear resistance offers at least 2:1 potential reward versus planned risk.
- No imminent earnings, clinical-trial readout, or other major catalyst creates unacceptable gap risk.
*Probabilities are rough illustrative estimates based on scanner score, RSI reading, and distance to support. They are not statistical forecasts and can change quickly with price action or news.
Comments
Post a Comment